Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft thrombosis (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
Warfarin showed no clear difference in graft thrombosis (up to 37 months) compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications (up to 37 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Graft thrombosis (up to 12 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
Fish oil showed no clear difference in graft thrombosis (up to 12 months) compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications (up to 12 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
1 finding from 1 review
Radiological or surgical intervention (up to 12 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
Fish oil showed no clear difference in radiological or surgical intervention (up to 12 months) compared with placebo (moderate certainty).
1 finding from 1 review
Fistula thrombosis (42 days to 6 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula
Clopidogrel showed no clear difference in fistula thrombosis (42 days to 6 months) compared with placebo (moderate certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complication: all bleeding (up to 6 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula
Clopidogrel showed no clear difference in complication: all bleeding (up to 6 months) compared with placebo (moderate certainty).
1 finding from 1 review
Complication: mortality (up to 6 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula
Clopidogrel probably leads to higher complication: mortality (up to 6 months) compared with placebo (moderate certainty).
1 finding from 1 review
Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula
Clopidogrel showed no clear difference in number of related surgical or radiological interventions (42 days) compared with placebo (moderate certainty).
1 finding from 1 review
Complications (28 days to 18 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
1 finding from 1 review
Graft thrombosis (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
Sulphinpyrazone showed no clear difference in graft thrombosis (up to 3 months) compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found